|
MAPK7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62581059726108E-12 |
| Normal-vs-Stage2 |
6.409700E-04 |
| Normal-vs-Stage3 |
6.02040639563484E-12 |
| Normal-vs-Stage4 |
3.95490307170121E-11 |
| Stage1-vs-Stage2 |
7.535900E-02 |
| Stage1-vs-Stage3 |
5.102400E-01 |
| Stage1-vs-Stage4 |
7.114800E-01 |
| Stage2-vs-Stage3 |
6.043800E-02 |
| Stage2-vs-Stage4 |
7.511500E-02 |
| Stage3-vs-Stage4 |
8.454000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62803104331033E-12 |
| Normal-vs-AfricanAmerican |
1.94969995703786E-09 |
| Normal-vs-Asian |
1.121990E-02 |
| Caucasian-vs-AfricanAmerican |
1.071860E-02 |
| Caucasian-vs-Asian |
4.057800E-03 |
| AfricanAmerican-vs-Asian |
2.675600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.56838994516784E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.45489999999693E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.154700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.4432899320127E-15 |
| Normal-vs-Age(61-80Yrs) |
8.88178419700125E-15 |
| Normal-vs-Age(81-100Yrs) |
6.459100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.844600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.144800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.005000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.315000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.981650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.565600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.62625468647093E-12 |
| Normal-vs-Grade 2 |
1.60982338570648E-14 |
| Normal-vs-Grade 3 |
3.74478226206065E-12 |
| Normal-vs-Grade 4 |
2.72759592689908E-11 |
| Grade 1-vs-Grade 2 |
3.74040000000742E-05 |
| Grade 1-vs-Grade 3 |
1.820840E-04 |
| Grade 1-vs-Grade 4 |
2.119800E-03 |
| Grade 2-vs-Grade 3 |
7.137800E-01 |
| Grade 2-vs-Grade 4 |
1.552000E-01 |
| Grade 3-vs-Grade 4 |
1.298000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.64301905414277E-12 |
| Normal-vs-ccB subtype |
7.1220995767618E-10 |
| ccA subtype-vs-ccB subtype |
5.560400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.28381766223629E-12 |
| Normal-vs-N1 |
9.7172999646844E-09 |
| N0-vs-N1 |
5.164300E-02 |
|
|
